BIO-key International, Inc.
BKYI
$4.55
-$0.09-2.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.15M | 1.08M | 1.55M | 1.70M | 1.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.15M | 1.08M | 1.55M | 1.70M | 1.61M |
| Cost of Revenue | 376.30K | 271.40K | 358.00K | 464.20K | 279.50K |
| Gross Profit | 1.77M | 812.40K | 1.19M | 1.23M | 1.33M |
| SG&A Expenses | 1.31M | 1.83M | 1.40M | 1.68M | 1.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.30M | 2.79M | 2.44M | 2.78M | 2.25M |
| Operating Income | -157.70K | -1.71M | -892.20K | -1.08M | -640.60K |
| Income Before Tax | -205.00K | -4.27M | -964.80K | -1.17M | -736.50K |
| Income Tax Expenses | -- | 16.50K | -- | -- | -- |
| Earnings from Continuing Operations | -205.00K | -4.29M | -964.80K | -1.17M | -736.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -205.00K | -4.29M | -964.80K | -1.17M | -736.50K |
| EBIT | -157.70K | -1.71M | -892.20K | -1.08M | -640.60K |
| EBITDA | -87.00K | -1.64M | -814.60K | -983.40K | -542.60K |
| EPS Basic | -0.20 | -4.62 | -1.46 | -2.01 | -1.57 |
| Normalized Basic EPS | -0.12 | -1.19 | -0.92 | -1.25 | -0.98 |
| EPS Diluted | -0.20 | -4.62 | -1.46 | -2.01 | -1.57 |
| Normalized Diluted EPS | -0.12 | -1.19 | -0.92 | -1.25 | -0.98 |
| Average Basic Shares Outstanding | 1.04M | 929.40K | 658.80K | 582.10K | 470.20K |
| Average Diluted Shares Outstanding | 1.04M | 929.40K | 658.80K | 582.10K | 470.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |